All babies born in CT hospitals are screened for 52 selected genetic and metabolic disorders, usually within the first 48 hours of life. Now ALD is included in that list. The CT Department of Health implemented newborn screening for ALD in October 2015. In January, our first CT baby with ALD was identified. Because ALD …Read More
Newborn Screening is Expected to Save Babies from ALD!
We’re honored to work with great organizations such as Lorenzo’s Oil to fight to bring an end to ALD. Even though Lorenzo Odone couldn’t be saved, we hope our efforts continue to help #SaveTheBoys. Sylvia Burwell, the Health and Human Services Secretary, has recommended that every state begin screening newborns for ALD. Currently, New York …Read More
bluebird bio Announces Cerebral ALD Presentation at AAN Annual Meeting
Brian’s Hope is proud to share that bluebird bio in Cambridge, MA has announced that interim data for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented during the Clinical Trials at the American Academy of Neurology (AAN) 2016 Annual Meeting on April 20, 2016. Read the complete press release!
First Baby with ALD Identified in CT
It is bittersweet but good to know the process for ALD newborn screening is working in CT. In January, our first CT baby to have ALD was identified. The child is in the care of specialists and will receive the appropriate monitoring and treatments, which if given in the early phase, dramatically improve the outcome …Read More
ALD is Added to the Recommended Uniform Screening Panel (RUSP)!
On February 17th, 2016, the Secretary of the Department of Health & Human Services, Silvia Burwell, approved the addition of adrenoleukodystrophy (ALD) to the Recommended Uniform Screening Panel (RUSP), the federal list of genetic diseases recommended for state newborn screening programs. The addition of ALD to the RUSP will expedite the process of adding ALD …Read More
